期刊文献+

续断皂苷Ⅵ对小鼠骨髓基质干细胞成骨分化的影响 被引量:30

Effect of Asperosaponin Ⅵ on osteogenic differentiation of bone marrow stromal cells and anti-osteoporosis in mice
下载PDF
导出
摘要 目的:探讨续断皂苷VI(ASA VI)对小鼠骨髓基质干细胞(BMSCs)成骨分化的作用机制及对小鼠骨质疏松的防治作用。方法:采用MTT法、钙浓度检测及RT-q PCR方法评价ASA VI对BMSCs细胞活力、成骨分化及Wnt通路相关基因表达的作用;通过Micro-CT定量分析ASA VI对去卵巢(OVX)小鼠骨形态计量参数的影响。结果:适宜浓度下的ASA VI能提高BMSCs的细胞活力,促进细胞基质矿化,升高BMP-2、Runx2、β-catenin、OCN的基因表达,Wnt信号阻断剂(DKK-1)能降低这些成骨基因表达。ASA VI能增加OVX小鼠的股骨骨量,改善骨小梁微结构。结论:ASA VI促进BMSCs成骨分化,Wnt信号可参与了ASA VI诱导的成骨分化过程。 Objective: To investigate the underlying mechanisms of Asperosaponin VI (ASA VI) on bone marrow stromal cells (BMSCs) and the osteoprotective effect of ASA VI in mice after an ovariectomy (OVX). Methods: The effect of ASA VI at various concentrations on BMSCs proliferation, differentiation and express of mRNAs related to Wnt signal were measured with the MTT assay, calcium deposition assay and quantitative-RT-PCR, respectively. Micro-CT was employed for scanning the microstructural indices of the mice after an ovariectomy (OVX). Results: ASA VI at the appro-priate concentration enhanced the BMSCs proliferation, mineralization and osteogenic gene expression, including BMP- 2, Runx2, β-catenin, OCN. ASA VI-induced gene expression levels were significantly reduced by pretreatment with DKK- I. Moreover, ASA VI preserved the trabecular bone microarchitecture of OVX mice in vivo. Conclusion: ASA VI induced the BMSCs osteogenic differentiation by activating the Wnt/β-catenin pathway.
出处 《口腔颌面修复学杂志》 2017年第1期28-32,共5页 Chinese Journal of Prosthodontics
基金 博士后科学基金资助项目(项目编号:2016M591717) 上海市科学技术委员会资助项目(项目编号:16411960900) 上海市卫生局资助(项目编号:2014065)
关键词 续断皂苷VI 骨质疏松症 骨髓基质干细胞 成骨分化 asperosaponin VI osteoporosis bone marrow stromal cells osteogenic differentiation
  • 相关文献

参考文献5

二级参考文献101

  • 1程志安,吴燕峰,黄智清,曾志勇,谢文峰,罗懿明,萧劲夫,刘尚礼.续断对成骨细胞增殖、分化、凋亡和细胞周期的影响[J].中医正骨,2004,16(12):1-3. 被引量:80
  • 2王一涛,王家葵,杨奎,毛洁.续断的药理学研究[J].中药药理与临床,1996,12(3):20-23. 被引量:26
  • 3吴燕峰,程志安,沈慧勇,罗懿明,李庆明.续断含药血清对成骨细胞增殖的影响及其细胞毒性检测[J].中国临床康复,2006,10(1):66-68. 被引量:10
  • 4Rizzoli R,Bianchi ML,Garabedian M,McKay HA Moreno LA. Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly[J].Bone,2010.294-305.
  • 5Schettler AE,Gustafson EM. Osteoporosis prevention starts in adolescence[J].Journal of Academic Nurse Practition,2004.274-282.
  • 6Agnusdei D,Gentilella R. GH and IGF-I as therapeutic agents for osteoporosis[J].Journal of Endocrinological Investigation,2005.32-36.
  • 7Teitelbaum SL. Bone resorption by osteoclasts[J].Science,2000.1504-1508.
  • 8Zaidi M. Skeletal remodeling in health and disease[J].Nature Medicine,2007.791-801.
  • 9Bianchi ML. How to manage osteoporosis in children[J].Best Practice and Research:Clinical Rheumatology,2005.991-1005.
  • 10Park D,Spencer JA,Koh BI,Kobayashi T Fujisaki J Clemens TL Lin CP Kronenberg HM Scadden DT. Endogenous bone marrow MSCs are dynamic,fate-restricted participants in bone mainten-ance and regeneration[J].Cell Stem Cell,2012.259-272.

共引文献159

同被引文献490

引证文献30

二级引证文献369

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部